West Pharmaceutical Services | WST - Pre Tax Profit


West Pharmaceutical Services reported $161.5M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Align Technology USD 148.89M 27.71M Mar/2026
Avanos Medical USD 1.2M 2.4M Dec/2025
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Cerus USD -20.76M 17.9M Dec/2024
Charles River Laboratories USD -294.1M 464.13M Dec/2025
Cooper Companies USD 192.2M 75.4M Dec/2025
Dentsply International USD -42M 105M Mar/2026
Haemonetics USD 59.97M 8.69M Dec/2025
ICU Medical USD -15.9M 86.2M Dec/2025
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
J&J USD 8.66B 839M Jun/2026
Medtronic USD 2.45B 1.04B Mar/2026
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Neogen USD 28M 15.81M Sep/2025
OraSure Technologies USD -18.43M 5.14M Dec/2025
Quidel USD -79.5M 32.9M Mar/2026
Repligen USD 19.11M 2M Dec/2025
Rockwell Medical USD 343K 2.07M Jun/2024
Solventum Corp USD 332M 179M Dec/2025
STAAR Surgical USD -20.65M 39.44M Dec/2025
Terumo JPY 31.67B 13.71B Mar/2026
Utah Medical Products 418K 3K Sep/2024
West Pharmaceutical Services USD 161.5M 8.6M Dec/2025